(Q44495120)

3 December 2017

title

Modeling HIV dynamics and antiviral response with consideration of time-varying drug exposures, adherence and phenotypic sensitivity (English)

1 reference

3 December 2017

Yangxin Huang

1

1 reference

3 December 2017

Susan L Rosenkranz

series ordinal

2

1 reference

3 December 2017

Hulin Wu

series ordinal

3

1 reference

3 December 2017

publication date

1 August 2003

1 reference

3 December 2017

number of pages

22

1 reference

based on heuristic

inferred from page(s)

published in

Mathematical Biosciences

1 reference

3 December 2017

volume

184

1 reference

3 December 2017

issue

2

1 reference

3 December 2017

page(s)

165-186

1 reference

maintained by WikiProject

3 December 2017

WikiProject Mathematics

0 references

cites work

Stochastic modeling of the dynamics of CD4+ T-cell infection by HIV and some Monte Carlo studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

A stochastic model for primary HIV infection: optimal timing of therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

Production of resistant HIV mutants during antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

Epidemiological parameters of HIV transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

Relationships between antiviral treatment effects and biphasic viral decay rates in modeling HIV dynamics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

Modeling HIV infection of CD4+ T-cell subpopulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

Drug concentration heterogeneity facilitates the evolution of drug resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

Anti-viral drug treatment: dynamics of resistance in free virus and infected cell populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

Dynamics of HIV infection of CD4+ T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

Decay characteristics of HIV-1-infected compartments during combination therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

Adherence and drug resistance: predictions for therapy outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

Population HIV-1 dynamics in vivo: applicable models and inferential tools for virological data from AIDS clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end points

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

Assessing antiviral potency of anti-HIV therapies in vivo by comparing viral decay rates in viral dynamic models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

Pre-existence and emergence of drug resistance in HIV-1 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

Quasispecies dynamics and the emergence of drug resistance during zidovudine therapy of HIV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

Competition between zidovudine-sensitive and zidovudine-resistant strains of HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

Antigenic Diversity Thresholds and the Development of AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

Viral dynamics in human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

Pharmacokinetics of quinidine in male patients. A population analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

Effectiveness of 3TC in HIV clinical trials may be due in part to the M184V substitution in 3TC-resistant HIV-1 reverse transcriptase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

Evaluating treatment protocols to prevent antibiotic resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

HIV-1 infection and low steady state viral loads

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

Compliance in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

Adherence in AIDS clinical trials: a framework for clinical research and clinical care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

Simulation of clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2803%2900058-0

10.1016/S0025-5564(03)00058-0

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference